Lesion Sterilization Tissue Repair and Conventional Pulpectomy in Primary Molars
NCT ID: NCT06811636
Last Updated: 2026-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
74 participants
INTERVENTIONAL
2025-04-30
2028-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Lesion Sterilization and Tissue Repair Techniques Versus Pulpectomy in Primary Molars With Inflammed Pulp
NCT05336682
Postoperative Pain Intensity After Pulpotomy
NCT05424796
Lesion Sterilization And Tissue Repair Versus Zinc Oxide And Eugenol For Treatment of Necrotic Primary Molars
NCT05448937
The Effect of Cryotherapy on the Outcome of Pulpotomy and Root Canal Treatment
NCT06183021
Evaluatıon of the Effect of Pulpotomy Treatments Wıth Dıfferent Bıomaterıals on Postoperatıve Paın In Permanent Molars
NCT06784622
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The null hypothesis of the study is that there will be no significant difference in clinical and radiographic success between conventional root canal treatment and lesion sterilization tissue repair at any follow-up period.
The study plans to enroll 37 (thirty-seven) participants in the research group and 37 (thirty-seven) participants in the comparison group. The sample size was calculated based on the parameters derived from the study by Moura et al., which compared the clinical and radiographic success of conventional root canal treatment using zinc oxide eugenol and lesion sterilization tissue repair using a triple antibiotic paste. With a power level of 0.8, an alpha error probability of 0.05, and an effect size of 0.4020915, the required sample size was determined using the G\*Power 3.0.10 software (v.3.1.9.7, Universitat Kiel, Kiel, Germany).
In the comparison group, conventional pulpectomy (root canal treatment) using a calcium hydroxide-iodoform-based root canal filling paste will be performed on the teeth. In the research group, lesion sterilization tissue repair therapy will be carried out using a triple antibiotic mixture of metronidazole, ciprofloxacin, and clindamycin.
The common procedural steps for both groups will include:
Initial clinical examination and radiographic imaging, Administration of mandibular alveolar nerve block anesthesia using lidocaine hydrochloride with a vasoconstrictor, Rubber dam isolation to minimize bacterial contamination and protect soft and hard tissues, Removal of carious enamel and cavity preparation using a sterile diamond fissure and round burs with a water-cooled handpiece, Complete removal of carious dentin and the roof of the pulp chamber using low-speed tungsten carbide round burs and diamond fissure burs, Removal of coronal pulp tissue with a sharp sterile excavator, followed by irrigation of the pulp chamber with sterile saline to remove any pulp remnants.
Following these steps, the treatment will proceed according to the assigned group as outlined below:
Research Group:
For the lesion sterilization tissue repair method, a triple antibiotic paste will be placed in the pulp chamber. In previous studies, minocycline was used in the triple antibiotic paste; however, concerns about tooth discoloration associated with tetracycline derivatives have been reported. Although minocycline and clindamycin demonstrate similar success rates, a recent systematic review highlighted that mixtures containing tetracyclines are statistically less effective than those without tetracyclines. Consequently, the American Academy of Pediatric Dentistry recommends excluding tetracyclines in antibiotic mixtures used for non-vital pulp therapy in primary teeth. Based on this recommendation, the triple antibiotic paste will be prepared using commercially available metronidazole, ciprofloxacin, and clindamycin.
The tablets' enteric coatings and capsules will be removed, and each drug will be ground into a fine powder using a mortar and pestle. The powders will be stored separately in tightly sealed containers to prevent exposure to light and moisture. Equal parts of each powder will be measured using a precision balance with five decimal places and mixed on a glass slab to achieve a 1:1:1 ratio. A liquid mixture of propylene glycol and macrogol will be prepared in equal proportions and combined with the powders to form the paste. The final consistency of the triple antibiotic paste will be adjusted to a 7:1 powder-to-liquid ratio (70% hardness).
The canal orifices will be widened by 1-2 mm using a small, low-speed round bur, and the walls of the pulp chamber will be chemically cleaned with phosphoric acid for one minute. After rinsing with sterile saline and drying with cotton pellets, the triple antibiotic paste will be applied directly to the canal orifices and the pulp chamber floor. The teeth will then be sealed with glass ionomer cement and restored with stainless steel crowns.
Comparison Group:
The root length of the teeth will be determined using diagnostic radiographs. The canals will be enlarged by 2-3 file sizes beyond the initial file size using K-type endodontic files. During canal preparation, each file will be followed by irrigation with 2 mL of 2.5% sodium hypochlorite (NaOCl). After canal preparation, the canals will be irrigated with 2.5% NaOCl and finally with saline before drying with paper points. The canals will then be filled with a calcium hydroxide-iodoform paste. The pulp chamber will be sealed with glass ionomer cement, and the teeth will be restored with stainless steel crowns.
Postoperative periapical radiographs of the treated teeth will be obtained. Clinical evaluations will be performed at 1, 3, 6, 9, 12, 18, 24, 30 and 36 months to assess clinical success, while radiographic evaluations will be conducted at 3, 6, 12, 18, 24, 30 and 36 months to assess radiographic success rates in both groups.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group
Lesion sterilization and tissue repair
Lesion sterilization and tissue repair
Lesion sterilization and tissue repair therapy performed with a triple antibiotic mixture.
control group
Conventional pulpectomy
Conventional pulpectomy
Conventional pulpectomy with calcium hydroxide-iodoform based root canal paste.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lesion sterilization and tissue repair
Lesion sterilization and tissue repair therapy performed with a triple antibiotic mixture.
Conventional pulpectomy
Conventional pulpectomy with calcium hydroxide-iodoform based root canal paste.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The participant and their parent(s) have signed informed consent forms agreeing to participate in the study.
* The patient is systemically healthy.
* The patient's cooperation level is sufficient for performing the procedures.
* No history of allergic reactions to the materials and substances to be used.
* Mandibular primary molars diagnosed with pulp necrosis or irreversible pulpitis.
* Presence of endodontic-origin gingival abscess or fistula in the involved teeth.
* History of spontaneous pain.
* Presence of radiolucency in the furcation or periapical region, not exceeding one-third of the affected area.
* Presence of deep dentin caries causing pulp exposure.
* Presence of mobility at level 0 or 1 according to Miller's classification (non-pathologic).
* The tooth meets the criteria for restorability.
* Root resorption does not exceed more than four-fifths of the root.
* The tooth meets the criteria for isolation.
Exclusion Criteria
* The participant and/or their parent(s) have not agreed to participate in the study or have not signed the informed consent forms.
* The patient has a systemic disease.
* The patient's cooperation level is insufficient to perform the procedures.
* The patient has a history of allergic reactions to the materials and substances to be used.
* Teeth with external or internal root resorption.
* Mechanical or carious perforation of the pulp floor in the affected teeth.
* Radiolucency and bone destruction in the furcation or periapical region exceeding one-third of the affected area.
* Presence of caries that does not cause pulp exposure.
* Pathological mobility according to Miller's classification (\>1 score).
* The tooth does not meet the criteria for restorability.
* Root resorption exceeds more than four-fifths of the root.
* The tooth does not meet the criteria for isolation.
3 Years
8 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Çanakkale Onsekiz Mart University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sümeyye ŞENOL
Research Assistant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sümeyye Şenol, R.A.
Role: PRINCIPAL_INVESTIGATOR
Çanakkale Onsekiz Mart University
Berkant Sezer, Assoc. Prof.
Role: PRINCIPAL_INVESTIGATOR
Çanakkale Onsekiz Mart University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Canakkale Onsekiz Mart University
Çanakkale, Kepez, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CanakkaleOMU1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.